Intra-Cellular Therapies

Showing 2 posts of 2 posts found.

Intra-Cellular Therapies shares phase 3 results for major depressive disorder therapy

April 17, 2024
Research and Development Intra-Cellular Therapies, Neurology, clinical trial, major depressive disorder, mental health

Intra-Cellular Therapies has announced positive topline results from Study 501, which assessed lumateperone 42mg as an adjunctive therapy to antidepressants …

rawlins_nice

NICE chairman joins biotech Board

May 17, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Intra-Cellular Therapies, NICE, Rawlins

Biotech firm Intra-Cellular Therapies has appointed former NICE chairman Professor Sir Michael Rawlins to its Board of directors. Rawlins was …

Latest content